Copertina

Meta‐Analysis: Efficacy and Safety of Sequestrants for Bile Acid Diarrhoea

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Saam Dilmaghani, Joelle BouSaba, Camille Lupianez‐Merly, Larry Prokop, M. Hassan Murad, Michael Camilleri
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Alimentary Pharmacology & Therapeutics
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Review article: Pharmacologic management of obesity ‐ updates on approved medications, indications and risks
di: Camille Lupianez‐Merly, et al.
Pubblicazione: (2024)

Letter (brief communication): A pilot study of hemp hull bio gut fibre (BGF) to reduce intestinal permeability in IBS‐BAD
di: Camille Lupianez‐Merly, et al.
Pubblicazione: (2024)

Disordered Bile Acid Metabolism in Alcohol‐Related Hepatitis
di: Luke D. Tyson, et al.
Pubblicazione: (2026)

Review Article: Surrogate Endpoints to Assess Treatment Efficacy in Disorders of Gut–Brain Interaction of Lower Gastrointestinal Tract
di: Michael Camilleri, et al.
Pubblicazione: (2025)

Review: Human Intestinal Barrier—Optimal Measurement and Effects of Diet in the Absence of Overt Inflammation or Ulceration
di: Michael Camilleri
Pubblicazione: (2025)

Network Meta‐Analysis: Comparative Efficacy of Biologics and Small Molecules in the Induction and Maintenance of Remission in Crohn's Disease
di: Mohammad Shehab, et al.
Pubblicazione: (2025)

Letter: From Safety to Precision—Optimising the Use of GLP‐1 Receptor Agonists in Gastroenterology
di: Joëlle St‐Pierre, et al.
Pubblicazione: (2026)

Review Article: Drug Approval for Gastroparesis—Suggestions for Improving the Process for Positive Results
di: Michael Camilleri, et al.
Pubblicazione: (2026)

Editorial: The Devil Is in the Detail—Interpreting the Findings of Network Meta‐Analyses. Authors' Reply
di: Mohammad Shehab, et al.
Pubblicazione: (2025)

Review Article: The Evolving Role of GLP ‐1 Receptor Agonists in Gastroenterology Practice
di: Sydney Pomenti, et al.
Pubblicazione: (2025)

Clinical Trial: Safety and Efficacy of a Novel Oesophageal Delivery System for Topical Corticosteroids Versus Placebo in the Treatment of Eosinophilic Oesophagitis
di: Alfredo J. Lucendo, et al.
Pubblicazione: (2024)

Clinical Trial: Study to Investigate the Efficacy and Safety of the Alpha‐2‐Delta Ligand PD‐217,014 in Patients With Irritable Bowel Syndrome
di: Lesley A. Houghton, et al.
Pubblicazione: (2025)

Meta‐Analysis: Exclusive Enteral Nutrition in Adults With Ulcerative Colitis
di: Matthew K. W. Chu, et al.
Pubblicazione: (2025)

Meta‐Analysis: Prevalence of Eating Disorders in Inflammatory Bowel Disease
di: Quinn Goddard, et al.
Pubblicazione: (2025)

Meta‐analysis: Efficacy and safety of fibroblast growth factor 21 analogues for the treatment of non‐alcoholic steatohepatitis and non‐alcoholic steatohepatitis‐related fibrosis
di: Rutao Lin, et al.
Pubblicazione: (2024)

Meta‐Analysis: Prevalence and Incidence of Gastroparesis Following Lung or Heart Transplantation
di: Mohamed H. Eldesouki, et al.
Pubblicazione: (2026)

Meta‐Analysis: Pregnancies With Inflammatory Bowel Disease Complicated by Intrahepatic Cholestasis of Pregnancy
di: Shamim Joudaki, et al.
Pubblicazione: (2025)

Meta‐Analysis: Mortality Trends and Risk Factors in Severe Alcohol‐Associated Hepatitis
di: Mushfiqur R. Siddique, et al.
Pubblicazione: (2025)

Meta‐Analysis: Improvement of Bowel Urgency With Advanced Therapies for Inflammatory Bowel Disease
di: Purab Patel, et al.
Pubblicazione: (2025)

Integrated Analysis of Vonoprazan Safety for Symptomatic Gastro‐Oesophageal Reflux Disease or Erosive Oesophagitis
di: Colin W. Howden, et al.
Pubblicazione: (2024)

Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment
di: Grace Lai‐Hung Wong, et al.
Pubblicazione: (2025)

Letter: Meta‐Analysis: Prevalence of Frailty and Associated Adverse Events in Inflammatory Bowel Disease
di: Cong Dai, et al.
Pubblicazione: (2024)

Letter: Meta‐Analysis Critique: Refining the Association Between Helicobacter pylori and Eosinophilic Oesophagitis
di: Haleema Rahman
Pubblicazione: (2025)

Letter on “Efficacy and Safety of Tenofovir Alafenamide ( TAF ) and Tenofovir Disoproxil Fumarate ( TDF ) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment”
di: Yan Liu, et al.
Pubblicazione: (2025)

Meta‐Analysis: Global Prevalence and Mortality of Cirrhosis in Metabolic Dysfunction‐Associated Steatotic Liver Disease
di: Soroor Owrangi, et al.
Pubblicazione: (2024)

Letters on “Efficacy and Safety of Tenofovir Alafenamide ( TAF ) and Tenofovir Disoproxil Fumarate ( TDF ) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment.” Authors' Reply
di: Grace Lai‐Hung Wong, et al.
Pubblicazione: (2025)

Letter: Meta‐Analysis: Prevalence of Frailty and Associated Adverse Events in Inflammatory Bowel Disease—Authors' Reply
di: Isabel Carbery, et al.
Pubblicazione: (2024)

Letter on ‘Meta‐Analysis: Mortality Trends and Risk Factors in Severe Alcohol‐Associated Hepatitis’—Authors' Reply
di: Francisco Idalsoaga, et al.
Pubblicazione: (2025)

Meta‐Analysis of Placebo‐Treated Patients: Dropout Rates From Treatment in MASH Randomised Controlled Trials
di: Matheus Souza, et al.
Pubblicazione: (2025)

Efficacy and Safety of Vedolizumab and Tofacitinib ( VETO ) Combination Therapy in Refractory Ulcerative Colitis Unresponsive to Anti‐ TNF and a Second‐Line Advanced Therapy: A Prospective Cohort Nested Within a Randomised Trial
di: Pardhu Bharath Neelam, et al.
Pubblicazione: (2025)

Statin Therapy Independently Reduces Mortality and Liver Complications in Patients With Cirrhosis: An Updated Systematic Review and Meta‐Analysis
di: Bernardo de Faria Moraes, et al.
Pubblicazione: (2026)

Waitlist and Post‐Transplant Outcomes in Liver Transplantation for Alcohol‐Associated Liver Disease: An Individual Patient Data Meta‐Analysis
di: Glenn Jun Kit Ho, et al.
Pubblicazione: (2025)

Steatotic Liver Disease Prevalence in China: A Population‐Based Study and Meta‐Analysis of 17.4 Million Individuals
di: Zhenqiu Liu, et al.
Pubblicazione: (2025)

Network Meta‐Analysis: Comparison of Pharmacological Therapies in Compensated Metabolic Dysfunction‐Associated Steatohepatitis Cirrhosis for Fibrosis Regression and MASH Resolution
di: Matheus Souza, et al.
Pubblicazione: (2026)

Letter: Liver Transplantation Outcomes for Alcohol‐Associated Liver Disease—Commentary on an Individual Patient Data Meta‐Analysis and Future Research Directions
di: Xinglin Li, et al.
Pubblicazione: (2026)

Meta‐Analysis: High anti‐ HBs Titers are Associated with Significantly Reduced Risk of Hepatitis B Virus Reactivation During Rituximab Treatment
di: Shiva Poola, et al.
Pubblicazione: (2025)

Mortality of Acute Kidney Injury in Cirrhosis: A Systematic Review and Meta‐Analysis of Over 5 Million Patients Across Different Clinical Settings
di: Vasileios Lekakis, et al.
Pubblicazione: (2024)

Letter: Liver Transplantation Outcomes for Alcohol‐Associated Liver Disease—Commentary on an Individual Patient Data Meta‐Analysis and Future Research Directions. Authors' Reply
di: Ryan Yanzhe Lim, et al.
Pubblicazione: (2026)

Meta‐analysis: Intestinal ultrasound to evaluate colonic contents and constipation
di: R. M. Mathias, et al.
Pubblicazione: (2024)

Editorial: The Devil Is in the Detail—Interpreting the Findings of Network Meta‐Analyses
di: Christy Riggott, et al.
Pubblicazione: (2025)